A novel Glu421Lys substitution in the lipoprotein lipase gene in pregnancy-induced hypertriglyceridemic pancreatitis

被引:42
作者
Henderson, H
Leisegang, F
Hassan, F
Hayden, M
Marais, D
机构
[1] Univ British Columbia, Dept Med Genet, Vancouver, BC V6T 1Z4, Canada
[2] Univ Cape Town, Inst Child Hlth, Dept Chem Pathol, ZA-7925 Cape Town, South Africa
[3] Univ Cape Town, Dept Med, ZA-7925 Cape Town, South Africa
关键词
hypertriglyceridemia; pregnancy; LPL deficiency; LPL gene mutation;
D O I
10.1016/S0009-8981(97)00144-7
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Severe hypertriglyceridemia is an uncommon pathological finding in pregnant women if there is no prior history of hyperlipidemia. A partial reduction in lipoprotein lipase (LPL) activity due to a mutation in the LPL gene, is often an associating factor. Here we report a novel LPL gene mutation (Glu421Lys), in a previously healthy primigravid woman who died from hypertriglyceridemia-induced pancreatitis during the last trimester of pregnancy. The patient was heterozygous for this mutation which causes a charge inversion in the C-terminal domain of LPL resulting in a moderate reduction in catalytic activity, both in vivo and in vitro. These data support the role of partial LPL deficiency in the pathogenesis of severe gestational hypertriglyceridemia. (C) 1998 Elsevier Science B.V.
引用
收藏
页码:1 / 12
页数:12
相关论文
共 35 条
  • [1] MECHANISM OF HYPERTRIGLYCERIDEMIA IN HUMAN APOLIPOPROTEIN-(APO)-CIII TRANSGENIC MICE - DIMINISHED VERY LOW-DENSITY-LIPOPROTEIN FRACTIONAL CATABOLIC RATE ASSOCIATED WITH INCREASED APO-CIII AND REDUCED APO-E ON THE PARTICLES
    AALTOSETALA, K
    FISHER, EA
    CHEN, XL
    CHAJEKSHAUL, T
    HAYEK, T
    ZECHNER, R
    WALSH, A
    RAMAKRISHNAN, R
    GINSBERG, HN
    BRESLOW, JL
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1992, 90 (05) : 1889 - 1900
  • [2] BERGERON J, 1992, CLIN GENET, V41, P206
  • [3] Bijvoet S, 1996, J LIPID RES, V37, P640
  • [4] LIPOPROTEIN-LIPASE SECRETION BY HUMAN MONOCYTE-DERIVED MACROPHAGES
    CHAIT, A
    IVERIUS, PH
    BRUNZELL, JD
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1982, 69 (02) : 490 - 493
  • [5] CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2
  • [6] DALLONGEVILLE J, 1992, J LIPID RES, V33, P447
  • [7] AN APOLIPOPROTEIN CIII HAPLOTYPE PROTECTIVE AGAINST HYPERTRIGLYCERIDEMIA IS SPECIFIED BY PROMOTER AND 3' UNTRANSLATED REGION POLYMORPHISMS
    DAMMERMAN, M
    SANDKUIJL, LA
    HALAAS, JL
    CHUNG, W
    BRESLOW, JL
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (10) : 4562 - 4566
  • [8] MARKED HYPERLIPIDEMIA AND PANCREATITIS ASSOCIATED WITH ORAL-CONTRACEPTIVE THERAPY
    DAVIDOFF, F
    TISHLER, S
    ROSOFF, C
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1973, 289 (11) : 552 - 555
  • [9] DECHALAIN TMB, 1988, SURG GYNECOL OBSTET, V167, P469
  • [10] MOLECULAR SCREENING OF THE LIPOPROTEIN-LIPASE GENE IN HYPERTRIGLYCERIDEMIC MEMBERS OF FAMILIAL NONINSULIN-DEPENDENT DIABETES-MELLITUS FAMILIES
    ELBEIN, SC
    YEAGER, C
    KWONG, LK
    LINGAM, A
    INOUE, I
    LALOUEL, JM
    WILSON, DE
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1994, 79 (05) : 1450 - 1456